What You Should Know:
– Upstart technology innovator Piramidal has secured $6 million in seed funding to aid its development of a barrier-breaking artificial intelligence (AI) model that will help neurologists assess brainwave data, with the potential to democratize analysis and shorten patient waiting time.
– The seed funding round attracted high-profile investors, including Y Combinator, Adverb Ventures, Lionheart Ventures, and angel investors such as founders of Intercom, Plangrid, and Guilded. These backers recognize Piramidal’s potential to transform the way brain conditions are diagnosed.
Piramidal’s AI Model Revolutionizes Brain Condition Diagnostics with $6 Million Seed Funding
Piramidal has developed a proprietary model that utilizes advanced machine learning and electroencephalography (EEG) analysis to simplify and streamline the complex process of diagnosing brain conditions. Initially focused on epilepsy, the model has demonstrated the ability to:
– Reduce review time
– Minimize error margins
Looking ahead, Piramidal plans to refine its model for broader applications, including:
– Neurology diagnosis
– Drug discovery
– Remote monitoring of brainwave abnormalities
– Real-time brain health tracking
Innovative Approach: Training AI on Brainwaves
Piramidal’s model is trained on brainwaves, similar to how Large Language Learning Models (LLMs) are trained on text. This unique approach enables the model to:
– Understand and detect various facets of brain activity
– Assist in diagnosing diseases
– Monitor overall brain well-being
Addressing Key Challenges in AI Deployment
The $6 million in seed funding comes at a critical time, as budgetary constraints have been a significant barrier to the widespread deployment of AI in healthcare. As highlighted in a recent Forbes article, AI has the potential to offer substantial financial and workforce efficiency gains. However, the high cost of developing and tailoring AI technology to specific healthcare goals has been a major obstacle.
Piramidal’s Impact on EEG Analysis
Currently, EEG data for patients with brain-related conditions is manually reviewed by neurologists—a process that is both time-consuming and prone to errors, with up to a 30% margin of error. Piramidal’s model aims to revolutionize this process by:
– Quickly processing and understanding EEG data
– Delivering faster and more accurate diagnoses
This innovation will not only save doctors time but also reduce patient wait times and lower healthcare costs.
According to Kris Pahuja, Co-founder and Chief Product Officer, the seed funding will provide the necessary resources to further train the model and accelerate its market launch, ultimately benefiting both patients and medical professionals through enhanced efficiency.
“No one else is building an EEG model like ours,” says Piramidal Co-founder & CEO Dimitris Sakellariou, who has a PhD in neuroscience and AI and industry experience building foundation models.
